Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1985 3
1986 18
1987 1
1989 3
1996 2
1999 1
2000 1
2002 3
2003 5
2004 2
2005 8
2006 5
2007 6
2008 4
2009 13
2010 9
2011 17
2012 12
2013 6
2014 12
2015 8
2016 9
2017 6
2018 10
2019 18
2020 20
2021 22
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

216 results
Results by year
Filters applied: . Clear all
Page 1
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.
Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M, Paluchowski P, Solbach C, Blohmer JU, Kühn T, The Axsana Study Group. Banys-Paluchowski M, et al. Among authors: thill m. Cancers (Basel). 2021 Mar 29;13(7):1565. doi: 10.3390/cancers13071565. Cancers (Basel). 2021. PMID: 33805367 Free PMC article. Review.
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial.
Gianni L, Mansutti M, Anton A, Calvo L, Bisagni G, Bermejo B, Semiglazov V, Thill M, Chacon JI, Chan A, Morales S, Alvarez I, Plazaola A, Zambetti M, Redfern AD, Dittrich C, Dent RA, Magazzù D, De Fato R, Valagussa P, Tusquets I. Gianni L, et al. Among authors: thill m. JAMA Oncol. 2018 Mar 1;4(3):302-308. doi: 10.1001/jamaoncol.2017.4612. JAMA Oncol. 2018. PMID: 29327055 Free PMC article. Clinical Trial.
Benign Breast Diseases.
Thill M. Thill M. Breast Care (Basel). 2018 Dec;13(6):400-401. doi: 10.1159/000495918. Epub 2018 Dec 12. Breast Care (Basel). 2018. PMID: 30800033 Free PMC article. No abstract available.
Biosimilars: what the oncologist should know.
Thill M, Thatcher N, Hanes V, Lyman GH. Thill M, et al. Future Oncol. 2019 Apr;15(10):1147-1165. doi: 10.2217/fon-2018-0728. Epub 2019 Feb 22. Future Oncol. 2019. PMID: 30793950 Free article. Review.
[Assessment of hypoacusis].
Ducène C, Thill MP. Ducène C, et al. Among authors: thill mp. Rev Med Brux. 2013 Sep;34(4):239-44. Rev Med Brux. 2013. PMID: 24195234 Review. French.
Emerging gonadotropin-releasing hormone agonists.
Beyer DA, Amari F, Thill M, Schultze-Mosgau A, Al-Hasani S, Diedrich K, Griesinger G. Beyer DA, et al. Among authors: thill m. Expert Opin Emerg Drugs. 2011 Jun;16(2):323-40. doi: 10.1517/14728214.2010.547472. Epub 2011 Jan 19. Expert Opin Emerg Drugs. 2011. PMID: 21244327 Review.
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study.
Gianni L, Huang CS, Egle D, Bermejo B, Zamagni C, Thill M, Anton A, Zambelli S, Bianchini G, Russo S, Ciruelos EM, Greil R, Semiglazov V, Colleoni M, Kelly C, Mariani G, Del Mastro L, Maffeis I, Valagussa P, Viale G. Gianni L, et al. Among authors: thill m. Ann Oncol. 2022 May;33(5):534-543. doi: 10.1016/j.annonc.2022.02.004. Epub 2022 Feb 17. Ann Oncol. 2022. PMID: 35182721 Clinical Trial.
Hearing aid and Koebner phenomenon.
Lechien JR, Scheers C, Horoi M, Thill MP. Lechien JR, et al. Among authors: thill mp. Clin Case Rep. 2020 Mar 6;8(5):883-885. doi: 10.1002/ccr3.2762. eCollection 2020 May. Clin Case Rep. 2020. PMID: 32477539 Free PMC article.
216 results